Insulin sensitizer C59, identified by its CAS number 2761446-81-3, is a chemical compound that has garnered attention in the field of diabetes research, particularly for its potential role in enhancing insulin sensitivity. This compound is part of a broader class of insulin sensitizers that aim to improve glucose metabolism and reduce insulin resistance, which is a key factor in type 2 diabetes. C59 operates through mechanisms that may involve modulation of specific signaling pathways related to glucose uptake and metabolism. Its chemical structure includes functional groups that contribute to its biological activity, although detailed structural information is typically found in specialized chemical databases. Research into C59 is ongoing, with studies focusing on its efficacy, safety profile, and potential therapeutic applications. As with many investigational compounds, understanding its pharmacokinetics, pharmacodynamics, and long-term effects is crucial for determining its viability as a treatment option.

Insulin sensitizer C59

2761446-81-3: Insulin sensitizer C59, identified by its CAS number 2761446-81-3, is a chemical compound that has garnered attention in the field of diabetes research, particularly for its potential role in enhancing insulin sensitivity. This compound is part of a broader class of insulin sensitizers that aim to improve glucose metabolism and reduce insulin resistance, which is a key factor in type 2 diabetes. C59 operates through mechanisms that may involve modulation of specific signaling pathways related to glucose uptake and metabolism. Its chemical structure includes functional groups that contribute to its biological activity, although detailed structural information is typically found in specialized chemical databases. Research into C59 is ongoing, with studies focusing on its efficacy, safety profile, and potential therapeutic applications. As with many investigational compounds, understanding its pharmacokinetics, pharmacodynamics, and long-term effects is crucial for determining its viability as a treatment option.

<p>Insulin sensitizer C59 is an orally available insulin sensitizer that improves glucose uptake and can be used to study insulin-stimulated GLUT4 translocation.</p>

CAS 2761446-81-3

Insulin sensitizer C59

Insulin sensitizer C59

Ref: TM-T87943

Insulin sensitizer C59

Ref: 54-BUP02308